Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Counsel

Wei Xu

Goodwin Procter

main

Xu Wei

Goodwin counsel Wei Xu, from Washington, DC, is a member of the firm's Business Law department.

Wei Xu

Areas of Practice

Credentials

Education

JD2016

BA2010

Admissions

Bars

Related Content

Goodwin Advises Tubulis on Acquisition by Gilead for $3.15 Billion Upfront and Up to $1.85 Billion in Milestones

Goodwin Advises Ouro Medicines on Acquisition by Gilead Sciences for $1.675 Billion Upfront and Up To $500 Million in Milestones for a Total of Up To $2.375 Billion

Goodwin Advises Abra on Becoming a Public Company via Business Combination With New Providence Acquisition Corp. III

Goodwin Advises PennyMac on Acquisition of Cenlar’s Subservicing Business for $172.5 Million Upfront and Up to $85 Million in Consideration

Goodwin Advises Orna Therapeutics in Acquisition by Eli Lilly for Up to $2.4 Billion

Goodwin Advises Semler Scientific in All-Stock Merger with Strive

Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business For €760 Million

Goodwin Advises Enfusion in $1.5 Billion Acquisition by Clearwater Analytics

Public Company Advisory Practice

Mergers & Acquisitions

Special Purpose Acquisition Companies (SPACs)